Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

OBJECTIVES: To evaluate the difference between low-molecular-weight heparin (LMWH) and aspirin in preventing early neurological deterioration (END) and recurrent ischemic stroke (RIS), post-recovery independence, and safety outcomes in acute ischemic stroke. MATERIALS AND METHODS: We performed syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Hui, Wang, Ziyao, Tian, Min, Liu, Zunjing, Zhou, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908308/
https://www.ncbi.nlm.nih.gov/pubmed/35281068
http://dx.doi.org/10.3389/fimmu.2022.823391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908308/
https://www.ncbi.nlm.nih.gov/pubmed/35281068
http://dx.doi.org/10.3389/fimmu.2022.823391

Ejemplares similares